Diagnostics firm secures €2m for blood test for pregnant women

20th May, 2018
Clockwise from left: Frank Walsh, partner, Enterprise Equity; Bill Liao, European investment partner, SOSventures; Charles Garvey, chief executive, Metabolomic Diagnostics; and Professor Louise Kenny, consultant obstetrician at CUMH and director of the INFANT Centre with four-day-old baby Molly

Company: Metabolomic Diagnostics

Done Deal:€2 million EU funding

The clincher:“We plan to market the product next year, and with this support from EU, we believe that PrePsia has the potential to become part of pregnancy screening programmes worldwide” - Charles Garvey, chief executive, Metabolomic Diagnostics

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Content is king – just ask Netflix as rivals attempt to steal its crown

Tom Maguire: Tax changes we make now could help business for years

The Daily Briefing